 Investors reacted favorably over the announcement that Saluggia, Italy-based DiaSorin SpA MIL:DIA is paying 1.8 billion to purchase Austin, Texas-based Luminex Corp. NASDAQ:LMNX, a developer of proprietary biological testing technologies and products for the diagnostics, pharmaceutical and research industries worldwide. DiaSorins shares gained about 9 to 182 on Monday. 